Evaluation of the combination of a tissue-type plasminogen activator, SUN9216, and a thromboxane A2 receptor antagonist, vapiprost, in a rat middle cerebral artery thrombosis model. [electronic resource]
Producer: 19930803Description: 1077-81; discussion 1081-2 p. digitalISSN:- 0039-2499
- Animals
- Biphenyl Compounds -- pharmacology
- Cerebral Infarction -- drug therapy
- Disease Models, Animal
- Drug Combinations
- Drug Evaluation, Preclinical
- Heptanoic Acids -- pharmacology
- Intracranial Embolism and Thrombosis -- drug therapy
- Male
- Plasminogen Activators -- pharmacology
- Rats
- Rats, Wistar
- Receptors, Thromboxane -- antagonists & inhibitors
- Time Factors
- Tissue Plasminogen Activator -- pharmacology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.